
    
      The purpose of the study is to compare the efficacy and safety of Clobetasol propionate to
      that of its Vehicle in the treatment of mild to moderate plaque-type psoriasis. This is a
      multi-center, double blind, randomized, parallel designed study which consists of 2 weeks of
      treatment and a follow-up visit 2 weeks later.
    
  